Latest Commercialisation News

Iondrive Limited has marked a pivotal shift from development to commercialisation of its IONSolv™ technology, securing $4 million to target the US e-waste market and commissioning its pilot plant to refine critical minerals.

AnteoTech has marked significant progress in battery and life sciences sectors, highlighted by a major capital raise and strategic US partnership. The company is poised to convert promising trials into sales amid expanding market opportunities.

BlinkLab Limited has delivered strong diagnostic results in its U.S. autism pilot study, exceeding FDA performance thresholds and setting the stage for a pivotal 510(k) trial. The company also expanded its clinical trial network and nears completion of its European ADHD study.

Jade Gas Holdings reported continuous gas production from two wells at its Red Lake coal bed methane project in Mongolia during Q4 2025, confirming commercial viability with exceptionally high methane purity. The company also secured a $70 million non-binding LOI and appointed a new CEO to drive development.

Enlitic, Inc. reported its strongest quarter yet with record contract wins totalling A$4.3 million, alongside a strategic capital raise and new cost-saving measures to fuel growth.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

xReality Group Limited has reported its strongest quarter yet, with record cash receipts and a doubling sales pipeline, underpinned by major US defence contracts and expanded production capacity.

Vanadium Resources Limited is advancing its Steelpoortdrift Vanadium Project with a new CEO and a sharpened focus on near-term cash flow and critical mineral markets in the US and EU.

Swift TV Limited has reported robust Q2 activity with over 4,300 devices pre-sold, including a significant 2,000-device order from Chevron, positioning the company for a commercial rollout in Q3 FY26.